Showing results (71-80 of 177) with videos related to
Sort By:
Pageof 18
Haematologica|February 11, 2010
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersLaurent Brault, Christelle Gasser, Franz Bracher, et al.The Journal of Physiology|April 10, 2024
Coordinating activation of endo-lysosomal two-pore channels and TRP mucolipinsYu Yuan, Dawid Jaślan, Taufiq Rahman, et al.European Journal of Medicinal Chemistry|September 17, 2020
Synthesis, biological evaluation and toxicity of novel tetrandrine analoguesRamona Schütz, Martin Müller, Franz Geisslinger, et al.Steroids|May 30, 2015
Fungal sterol C22-desaturase is not an antimycotic target as shown by selective inhibitors and testing on clinical isolatesChristoph Müller, Ulrike Binder, Elisabeth Maurer, et al.Plos One|July 21, 2015
Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase InhibitorsKatharina Rüben, Anne Wurzlbauer, Agnes Walte, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 24, 2021
Effective sample preparation procedure for the analysis of free neutral steroids, free steroid acids and sterol sulfates in different tissues by GC-MSJulia Junker, Frits Kamp, Edith Winkler, et al.Archiv Der Pharmazie|January 28, 2014
Synthesis and biological evaluation of novel N-alkyl tetra- and decahydroisoquinolines: novel antifungals that target ergosterol biosynthesisJürgen Krauss, Christoph Müller, Julia Kießling, et al.Molecules (Basel, Switzerland)|February 13, 2025
Zephycandidine A and Synthetic Analogues-Synthesis and Evaluation of Biological ActivityThomas Klaßmüller, Florian Lengauer, Julia Blenninger, et al.Journal of Medicinal Chemistry|August 14, 2020
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor SelectivityMartin Schröder, Alex N Bullock, Oleg Fedorov, et al.European Journal of Medicinal Chemistry|April 16, 2013
Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitorsStefanie Lange, Marco Keller, Christoph Müller, et al.Pageof 18